South Pharmaceutical is a leading producer of paclitaxel and its intermediates in the Chinese pharmaceutical industry. It is the developer of the national standard "Technical Regulations for the Cultivation of Taxus mairei and Paclitaxel Raw Material Forests in the South," and one of the largest planting bases for Taxus mairei and production bases for paclitaxel and its intermediates in China. The company emphasizes technological innovation and the construction of its research and development team, holding 8 PCT international invention patents and 23 Chinese invention patents.
South Pharmaceutical has a strong sense of social responsibility, focusing on environmental protection and green development. It has a comprehensive environmental management and occupational health and safety management system (EHS system).
福(fu)建南方制(zhi)藥股份有(you)限公司(證(zheng)券代碼(ma):831207)成立于(yu)2001年9月(yue),致力于(yu)以(yi)紫(zi)杉醇(chun)原料藥為代表(biao)的(de)抗(kang)腫瘤藥物的(de)研發和生(sheng)產,是一家(jia)集藥物種(zhong)植(zhi)、研發、生(sheng)產、銷售于(yu)一體(ti)的(de)GMP制(zhi)藥企業。公司旗下雪峰(feng)、瀚仙兩個廠(chang)區占地面積共13.1萬平(ping)方米,擁有(you)4000畝優選南方紅豆杉種(zhong)植(zhi)基地。
南方(fang)制(zhi)(zhi)藥是中(zhong)(zhong)國(guo)制(zhi)(zhi)藥行業(ye)領先的紫杉烷(wan)類原(yuan)料藥及中(zhong)(zhong)間體產(chan)品(pin)生產(chan)企業(ye),是國(guo)家(jia)標(biao)準《南方(fang)紅(hong)豆杉紫杉醇(chun)原(yuan)料林豐產(chan)栽培技術規程》的制(zhi)(zhi)定者,是中(zhong)(zhong)國(guo)最大的紅(hong)豆杉種植基地和紫杉烷(wan)類產(chan)品(pin)生產(chan)供應基地之一。公司(si)重視(shi)技術革新(xin)和研發隊伍的建設(she),現有(you)8項PCT國(guo)際(ji)發明(ming)專(zhuan)利(li)、23項中(zhong)(zhong)國(guo)發明(ming)專(zhuan)利(li)。
南(nan)方制藥富(fu)有良好的社會(hui)責(ze)任感,致力于環境保護和綠色發展,擁有完備的環境管理和職業(ye)健(jian)康安(an)全管理體(ti)系(EHS體(ti)系)。
Fujian South Pharmaceutical Co., Ltd. (Stock Code: 831207) was established in September 2001. It is committed to the research and production of anti-tumor drugs, with paclitaxel as its representative, and is a GMP pharmaceutical enterprise integrating drug planting, research, production, and sales. The company's two factory areas, Xuefeng and Hanxian, cover a total area of 131,000 square meters and have a 4,000-acre high-quality southern yew planting base.
通過國家藥品(pin)GMP認證
Obtained National Drug GMP Certification
首次通過國家高技術(shu)企業資格認證
First-time accreditation as a National High-Tech Enterprise
旗下南方制藥(yao)公司新三板上市(證券代碼(ma):831207)
South Pharmaceutical Company, a subsidiary, listed on the New Third Board (Securities Code: 831207)
通過美(mei)國FDA現場審計
Passed on-site audit by the U.S. Food and Drug Administration (FDA)
榮獲(huo)高(gao)新技術企業(ye)、國(guo)家林業(ye)重點龍頭企業(ye)等(deng)稱號
Honored with titles such as High-Tech Enterprise and National Forestry Key Leading Enterprise
通過歐盟(meng)EDQM藥品質(zhi)量認(ren)證
Passed the European Directorate for the Quality of Medicines & HealthCare (EDQM) certification for drug quality
榮獲國家專精特新“小巨人”企業稱號(hao)
2021: Awarded the title of "National Specialized and Innovative 'Small Giant' Enterprise"
與上海熙(xi)華藥(yao)業合(he)作,投資「福建熙(xi)華醫(yi)藥(yao)產業園」
Cooperated with Shanghai Xihua Pharmaceutical Industry to invest in the 「Fujian Xihua Pharmaceutical Industrial Park」